Profluent is an AI-driven biotechnology company that designs novel proteins for applications in medicine, agriculture, and industry. Its platform uses artificial intelligence to author proteins, whether inspired by natural scaffolds or created from scratch. The company developed OpenCRISPR, described as the world's first AI-designed gene editor. Profluent has announced a strategic partnership with Eli Lilly to develop AI-designed recombinases for genetic medicine. The team combines machine learning and biology to solve protein design challenges.
Key Benefits
- AI-designed proteins for diverse applications
- World's first AI-designed gene editor (OpenCRISPR)
- Strategic partnership with Eli Lilly
- Expert team combining machine learning and biology